NCT05487781 is a EARLY_PHASE1 clinical trial of Tirfostina/L-Carnitina in Healthy, sponsored by Molecule X LLC.

Who is sponsoring NCT05487781?

NCT05487781 is sponsored by Molecule X LLC.

What drugs are being tested in NCT05487781?

Interventions in NCT05487781: Tirfostina/L-Carnitina.

Is NCT05487781 still recruiting?

NCT05487781 is currently status unknown. Last updated 4 August 2022.

Last reviewed 2022-08-04 · How we verify

NCT05487781

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Phase 1 Clinical Study to Describe Biological Safety and Pharmacokinetics of Tyrphostin

Status unknown EARLY_PHASE1 Last updated 4 August 2022

What this trial tests

EARLY_PHASE1 trial testing Tirfostina/L-Carnitina in Healthy in 48 participants. Status unknown.

Timeline

24 May 2022

Primary endpoint
28 June 2022

29 July 2022

Quick facts

Lead sponsor	Molecule X LLC
Phase	EARLY_PHASE1
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	double
Primary purpose	treatment
Enrollment	48
Start date	24 May 2022
Primary completion	28 June 2022
Estimated completion	29 July 2022
Sites	1 location across Mexico

Drugs / interventions tested

Tirfostina/L-Carnitina

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Molecule X LLC

Who can join

Adults 18 to 55, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the biological safety and pharmacokinetics of tyrphostin AG-17 present in the solid oral formulations of the fixed-dose combination, in three different concentrations of the compound tyrphostin AG-17 contained 10 mg, 3.3 mg and 1 mg, respectively, with 700 mg of L-Carnitine tartrate each presentation, in a single dose in healthy research subjects of Mexican nationality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05487781 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Molecule X LLC
Last refreshed: 4 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05487781.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing